Viz.ai Announces Agreement with Bristol Myers Squibb to Enable Earlier Detection and Management...
Viz.ai has submitted a de novo classification request to the FDA for a new AI algorithm intended to identify and...
Mar 02, 2023
Explore our News & Press
Viz.ai has submitted a de novo classification request to the FDA for a new AI algorithm intended to identify and...
Mar 02, 2023
Using Viz RECRUIT software, recruitment happens in real-time, around-the-clock, accelerating treatment development for patients with intracerebral hemorrhage SAN FRANCISCO, CA...
Feb 14, 2023
Study, across 166 facilities in 17 states, finds AI-powered care coordination crucial for acute stroke management SAN FRANCISCO - February...
Feb 08, 2023
End-to-end platform for vascular care teams to accelerate the detection and treatment of suspected vascular disease SAN FRANCISCO – January...
Jan 12, 2023
Healthcare technology leader recognized for its culture, diversity, career growth and outlook SAN FRANCISCO - December 15, 2022 - Viz.ai,...
Dec 15, 2022
New partnership incorporates latest perfusion technology into the Viz.ai platform SAN FRANCISCO - November 29, 2022 - Viz.ai, the leader in AI-powered...
Nov 30, 2022
Comprehensive solution tailored for radiologists to expedite patient diagnosis and treatment SAN FRANCISCO - November 28, 2022 - Viz.ai, the leader...
Nov 28, 2022
Leading experts to help shape the future of Viz.ai’s radiology strategy and platform SAN FRANCISCO - November 28, 2022- Viz.ai,...
Nov 28, 2022
Validates the Viz Aortic Dissection Detection algorithm with high sensitivity, specificity and positive predictive value. SAN FRANCISCO & NEW YORK--(BUSINESS...
Nov 18, 2022